Skip to main content
Equibles

Man Group plc

Position in JNJ — Johnson & Johnson

CIK 1637460 LONDON, X0
Back to JNJ Full portfolio

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$77,752,697
-$38,954,064 QoQ
Shares Held
318,085
-43.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 54.13678733671817.ToString("F0")% Shared 0.ToString("F0")% None 45.86321266328183.ToString("F0")%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Mar 31, 2026
CallValue
$60,694,452
CallShares
248,300
PutValue
$60,694,452
PutShares
248,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Man Group plc holds $1,645,149,077 across 10 Drug Manufacturers - General names. JNJ ranks #7 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 422,016 $388,157,656
2 ABBV
AbbVie Inc.
 1,774,415 $385,917,516
3 BMY
Bristol Myers Squibb Co
 5,658,497 $343,187,842
4 AZN
Astrazeneca PLC
 628,476 $123,948,035
5 MRK
Merck & Co., Inc.
 793,167 $95,410,057
6 GILD
Gilead Sciences, Inc.
 678,066 $94,502,057
7 JNJ
Johnson & Johnson
This page 		318,085 $77,752,697
8 BIIB
Biogen Inc.
 318,745 $58,435,520

All Filings in JNJ

Export CSV
49 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $60,694,452 248,300
2026-03-31 $60,694,452 248,300
2026-03-31 $77,752,697 318,085
2025-12-31 $116,706,761 563,937
2025-12-31 $63,347,395 306,100
2025-12-31 $63,347,395 306,100
2025-09-30 $31,410,148 169,400
2025-09-30 $104,599,130 564,120
2025-09-30 $31,076,392 167,600
2025-06-30 $11,456,250 75,000
2025-06-30 $69,460,159 454,731
2025-06-30 $7,301,450 47,800
2025-03-31 $28,839,576 173,900
2025-03-31 $143,929,218 867,880
2025-03-31 $29,950,704 180,600
2024-12-31 $27,694,730 191,500
2024-12-31 $27,694,730 191,500
2024-12-31 $119,941,608 829,357
2024-09-30 $114,343,537 705,563
2024-09-30 $18,004,866 111,100
2024-09-30 $18,004,866 111,100
2024-06-30 $10,523,520 72,000
2024-06-30 $111,255,383 761,189
2024-06-30 $10,450,440 71,500
2024-03-31 $156,853,609 991,552
2024-03-31 $8,921,916 56,400
2024-03-31 $8,921,916 56,400
2023-12-31 $9,890,294 63,100
2023-12-31 $9,780,576 62,400
2023-12-31 $64,266,376 410,019
2023-09-30 $55,817,995 358,382
2023-06-30 $125,375,771 757,466
2023-06-30 $728,288 4,400
2023-06-30 $728,288 4,400
2023-03-31 $31,000 200
2023-03-31 $31,000 200
2023-03-31 $80,048,665 516,443
2022-12-31 $107,597,161 609,098
2022-09-30 $61,987,605 379,454
2022-06-30 $77,445,126 436,286
2022-03-31 $170,899,874 964,283
2021-12-31 $257,639,801 1,506,049
2021-09-30 $270,626,356 1,675,705
2021-06-30 $293,542,791 1,781,855
2021-03-31 $245,333,953 1,492,753
2020-12-31 $148,266,909 942,095
2020-09-30 $114,496,311 769,051
2020-06-30 $109,724,306 780,234
2020-03-31 $113,966,131 869,108

Report a Problem

Category
Description
Email (optional, for follow-up)